Victor Javier Lara-Diaz

Dr. Victor Javier Lara-Diaz

orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 January 2017 in Journal of Physiology and Biochemistry
Verified
Journal Article
Open access
PDF file
VLVictor Javier Lara-Diaz
Victor Javier Lara-Diaz
ICInma Castilla-Cortázar
Inma Castilla-Cortázar
IMI Martín-Estal
I Martín-Estal
MGM García-Magariño
M García-Magariño
GAGa Aguirre
Ga Aguirre
UMU Muñoz
U Muñoz
Even though the liver synthesizes most of circulating IGF-1, it lacks its receptor under physiological conditions. However, according to previous studies, a damaged liver expresses the receptor. For this reason, herein, we examine hepatic histology and expression of genes encoding proteins of the cytoskeleton, extracellular matrix, and cell-cell molecules and inflammation-related proteins. A partial IGF-1 deficiency murine model was used to investigate IGF-1’s effects on liver by comparing wild-type controls, heterozygous igf1+/−, and heterozygous mice treated with IGF-1 for 10 days. Histology, microarray for mRNA gene expression, RT-qPCR, and lipid peroxidation were assessed. Microarray analyses revealed significant underexpression of igf1 in heterozygous mice compared to control mice, restoring normal liver expression after treatment, which then normalized its circulating levels. IGF-1 receptor mRNA was overexpressed in Hz mice liver, while treated mice displayed a similar expression to that of the controls. Heterozygous mice showed overexpression of several genes encoding proteins related to inflammatory and acute-phase proteins and underexpression or overexpression of genes which coded for extracellular matrix, cytoskeleton, and cell junction components. Histology revealed an altered hepatic architecture. In addition, liver oxidative damage was found increased in the heterozygous group. The mere IGF-1 partial deficiency is associated with relevant alterations of the hepatic architecture and expression of genes involved in cytoskeleton, hepatocyte polarity, cell junctions, and extracellular matrix proteins. Moreover, it induces hepatic expression of the IGF-1 receptor and elevated acute-phase and inflammation mediators, which all resulted in liver oxidative damage.

14 October 2015 in Journal of Translational Medicine
Verified
Journal Article
Open access
PDF file
JRJulieta Rodríguez-De-Ita
Julieta Rodríguez-De-Ita
ICInma Castilla-Cortázar
Inma Castilla-Cortázar
GAG. A. Aguirre
G. A. Aguirre
CSC. Sánchez-Yago
C. Sánchez-Yago
MSM. Olleros Santos-Ruiz
M. Olleros Santos-Ruiz
UMU. Muñoz
U. Muñoz
Insulin growth factor 1 (IGF-1) has multiple effects on metabolism. Much evidence suggests that the deficiency of this hormone increases insulin resistance, impairs lipid metabolism, augments oxidative damage and deregulates the neuro-hormonal axis. An inverse relationship between IGF-1 levels and the prevalence of Metabolic Syndrome (MetS) with its cardiovascular complications has been identified. However, the underlying mechanisms linking IGF-1 and MetS are still poorly understood. In order to elucidate such mechanisms, the aim of this work was to study, in mice with partial IGF-1 deficiency, liver expression of genes involved in glucose and lipid metabolism as well as serum levels of glucose, triglycerides and cholesterol, as well as liver malondialdehyde (MDA) levels, as a marker for oxidative damage. Three experimental groups were studied in parallel: Controls (CO), wild type mice (igf-1 +/+); untreated heterozygous mice (Hz, igf-1 +/−) and Hz (igf-1 +/−) mice treated with low doses of IGF-1 for 10 days (Hz + IGF-1). A reduction of IGF-1 serum levels in the Hz group was found, which was normalized by IGF-1 therapy. Serum levels of glucose, triglycerides and cholesterol were significantly increased in the untreated Hz group as compared to both controls and Hz + IGF-1 groups. The expression of genes involved in gluconeogenesis, glycogenolysis, lipid synthesis and transport, and catabolism were altered in untreated Hz animals and the expression of most of them was normalized by IGF-1 therapy; MDA was also significantly increased in the Hz untreated group. The mere partial IGF-1 deficiency is responsible for the reduction in the expression of genes involved in glucose and lipid metabolism, resulting in dyslipidemia and hyperglycemia. Such genetic alterations may seriously contribute to the establishment of MetS.

1 January 2015 in International Journal of Infectious Diseases
Verified
Journal Article
Open access
VAVíctor Arízaga-Ballesteros
Víctor Arízaga-Ballesteros
MAMario René Alcorta-García
Mario René Alcorta-García
LLLizzeth Carolina Lázaro-Martínez
Lizzeth Carolina Lázaro-Martínez
JAJesús Manuel Amézquita-Gómez
Jesús Manuel Amézquita-Gómez
JAJosé Manuel Alanís-Cajero
José Manuel Alanís-Cajero
VLVictor Javier Lara-Diaz
Victor Javier Lara-Diaz
SummaryBackground and ObjectivesThe transmembrane glycoprotein TREM-1 triggers an inflammatory response. Its soluble fraction (sTREM-1) has been shown to have diagnostic accuracy for late-onset neonatal sepsis (LONS). Until now, the potential of sTREM-1 to predict septic shock and/or death in septic neonates has not been explored. This study obtained estimates of the incidence and prevalence of septic shock and/or death in septic neonates for future sample size calculations for confirmatory studies and evaluated the feasibility of using sTREM-1 as a predictor of septic shock and/or death in neonates with LONS criteria.Study designA pilot study with a cross-sectional design was performed from May 1st to October 31st, 2012. The participants were hospitalized neonates who, after three days of life, were diagnosed as having LONS. Plasma sTREM-1 was quantified by ELISA. The main outcome measurement was the development of septic shock and/or death.ResultsOf 71 eligible subjects, nine (12.7%) progressed to septic shock and/or death. In the LONS-Non-Shock group, the sTREM-1 median and interquartile range (IQR) plasma value were 10 (10 to 70) pg/mL. In the LONS & Shock/Death group, the values were 567 (260 to 649) pg/mL. These values were significantly different (Mann-Whitney’s U test, p=0.001).A ROC curve for a proposed sTREM-1 cut-off value of 300 pg/mL exhibited an area under the curve of 0.884 (95% CI=0.73 to 1.0; p<0.0001), with a sensitivity of 0.78 (95% CI=0.46 to 0.94) and specificity of 0.97 (95% CI=0.92 to 0.99); PPV would be 0.78 (95% CI=0.46 to 0.94) and NPV 0.97 (95% CI=0.92 to 0.99).ConclusionsIn neonates with LONS, sTREM-1 has the potential to provide an excellent predictive value for septic shock/death. Larger sample sizes are needed to identify the optimal cut-off value of plasma sTREM-1 for this diagnosis and to provide diagnostic accuracy measures

1 April 2008 in Annals of Hepatology
Verified
Journal Article
Open access
ALAlberto López-Reyes
Alberto López-Reyes
NANetzahualcóyotl Arroyo-Curras
Netzahualcóyotl Arroyo-Curras
BCBeiman G Cano
Beiman G Cano
VLVictor Javier Lara-Diaz
Victor Javier Lara-Diaz
GGGustavo E Guajardo-Salinas
Gustavo E Guajardo-Salinas
JMJorge E. Moreno-Cuevas
Jorge E. Moreno-Cuevas
We assessed the anti-fibrotic effects of methanolic black bean extract antioxidants in a carbon tetrachloride (CCl4) liver injury model in rats. Experimentally intoxicated animals received CCl4 for eight weeks, the reference and test groups received daily intragastric quercetin or daily intragastric black bean extract. Liver fibrosis was assessed and quantified using morphometric analysis. Expression of fibrosis related genes was measured by real time RT-PCR. Qualitative and quantitative histological analysis showed that administration of 70 mg/kg b.w. of black bean extract reduced hepatic fibrosis index by 18% compared to positive controls (P 0.006), as a result of a decrease in type I (44.3% less, P 0.03) and type IV (68.9% less, P 0.049) collagen gene expression compared to CCl4-injured and Quercetin treated rats. In conclusion, we provide evidence that this methanol black bean extract ameliorates liver fibrosis and types I and IV collagen gene expression, in the animal model used. The compounds contained in this black bean extract exhibited strong antifibrotic effects in the CCl4 chronic liver injury model used; considering that this compounds are contained in a leguminous that has been used in human diet for a long time, their toxic potential should be very low, and this characteristic should favor their potential use in some other chronic or degenerative states that include an increase in inflammation and oxidative burst in their pathogenesis. Another possible application of this kind of extract could be its use as an antimicrobial or even antiparasitic therapeutic agent, although it is purely speculative.

1 December 2018 in Sensors and Actuators B: Chemical
Verified
Journal Article
Closed access
MAM. Mahdi Aeinehvand
M. Mahdi Aeinehvand
RFRute Fabiana Martins Fernandes
Rute Fabiana Martins Fernandes
MMMartín Francisco Jiménez Moreno
Martín Francisco Jiménez Moreno
VLVictor Javier Lara-Diaz
Victor Javier Lara-Diaz
MMMarc Madou
Marc Madou
SMSergio O. Martínez-Chapa
Sergio O. Martínez-Chapa

15 January 2009 in Basic & Clinical Pharmacology & Toxicology
Verified
Journal Article
Open access
PDF file
VLVictor Javier Lara-Diaz
Victor Javier Lara-Diaz
ÁGÁngel A. Gaytán‐Ramos
Ángel A. Gaytán‐Ramos
ADAlfredo José Dávalos‐Balderas
Alfredo José Dávalos‐Balderas
JSJesus Santos-Guzman
Jesus Santos-Guzman
BMBenito David Mata‐Cárdenas
Benito David Mata‐Cárdenas
JMJorge E. Moreno‐Cuevas
Jorge E. Moreno‐Cuevas
Abstract: We investigated the microbiological and toxicological effects of three Perla black bean extracts on the growth and culture of selected pathogenic microorganisms, the toxicity over Vero cell lines and anin vivorat model. Three different solvents were used to obtain Perla black bean extracts. All three Perla black bean extracts were tested for antibacterial and antiparasitic activity and further analysed for intrinsic cytotoxicity (IC50). Methanol Perla black bean extract was used for acute toxicity test in rats, with the up‐and‐down doping method. All Perla black bean extracts inhibited bacterial growth.Pseudomonas aeruginosa,Proteus vulgaris,Klebsiella oxytoca,Enterococcus faecalis,Staphylococcus aureus,Staphylococcus epidermidisandListeria monocytogenesshowed inhibition, whileEscherichia coliandEnterobacter aerogenesdid not. Acidified water and acetic acid Perla black bean extract were tested in parasites. The best IC50was observed forGiardia lamblia, while higher concentrations were active againstEntamoeba histolyticaandTrichomonas vaginalis. The Vero cells toxicity levels (IC50) for methanol, acidified water and acetic acid Perla black bean extract were [mean ± S.D. (95% CI)]: 275 ± 6.2 (267.9–282.0), 390 ± 4.6 (384.8–395.2) and 209 ± 3.39 (205.6–212.4) µg/ml, respectively.In vivoacute toxicity assays did not show changes in absolute organ weights, gross and histological examinations of selected tissues or functional tests. The acetic acid and methanol Perla black bean extract proved to exhibit strong antibacterial activity and the acidified water Perla black bean extract exerted parasiticidal effects againstGiardia lamblia,Entamoeba hystoliticaandTrichomonas vaginalis. The three Perla black bean extracts assayed over Vero cells showed very low toxicity and the methanol Perla black bean extractin vivodid not cause toxicity.